Polycystic Ovary Syndrome and Probiotics: A Natural Approach to an Inflammatory Disease

Polycystic ovary syndrome (PCOS) is a condition that affects about 15% of women of reproductive age and is correlated with infertility, insulin resistance, and obesity. The etiology of PCOS is multifactorial and genetic, endocrine, and metabolic causes are involved. New evidence suggests a link between microorganisms residing in the digestive tracts of humans and the development of PCOS. Moreover, an imbalance in the gut microbial community could be a possible factor for the onset of insulin resistance and obesity. Hyperandrogenism, a key feature of PCOS, could also play a critical role in shaping the microbiome community. Probiotics could modify the gut microbiota and serve as a potential treatment for PCOS. Here we disclose the association between PCOS and intestinal microbiota and the possible role of probiotics as a new treatment approach.

Automated summary

PCOS is a complex condition that may be influenced by factors such as gut microbial balance, hyperandrogenism, insulin resistance, and obesity. Probiotics could potentially play a role in modulating the gut microbiota and serve as a treatment approach for PCOS.